Discovery of Mechanism behind Precision Cancer Drug Opens Door for More Targeted Treatment (IMAGE)

University of Alberta Faculty of Medicine & Dentistry

Discovery of Mechanism behind Precision Cancer Drug Opens Door for More Targeted Treatment

Caption

University of Alberta oncologist and cell biologist Michael Hendzel (right) was part of a national research team that identified how a new class of cancer drugs known as PARP inhibitors work, opening the door to better targeted therapy for cancer patients.

Credit

Faculty of Medicine & Dentistry, University of Alberta

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.